Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 605,513 |
|
|||||
| News | - | ||||||
| Day High | 38.81 | Low High |
|||||
| Day Low | 38.21 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Halozyme Therapeutics Incorporated | HALO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.34 | -0.88% | 38.38 | 16:03:35 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 38.21 | 38.21 | 38.81 | 38.38 | 38.72 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 11,821 | 605,513 | $ 38.54 | $ 23,336,808 | - | 29.85 - 45.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:11:04 | 100 | $ 38.47 | USD |
Halozyme Therapeutics (HALO) Options Flow Summary
Halozyme Therapeutics Incorporated Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.88B | 126.82M | - | 829.25M | 281.59M | 2.22 | 17.33 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Halozyme Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HALO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 40.07 | 40.71 | 38.21 | 39.21 | 991,689 | -1.69 | -4.22% |
| 1 Month | 40.46 | 42.30 | 38.21 | 40.08 | 892,166 | -2.08 | -5.14% |
| 3 Months | 34.20 | 42.64 | 33.15 | 38.36 | 1,087,932 | 4.18 | 12.22% |
| 6 Months | 36.92 | 42.82 | 32.83 | 37.52 | 1,170,207 | 1.46 | 3.95% |
| 1 Year | 36.25 | 45.00 | 29.85 | 37.38 | 1,105,763 | 2.13 | 5.88% |
| 3 Years | 46.49 | 59.46 | 29.85 | 41.21 | 1,103,106 | -8.11 | -17.44% |
| 5 Years | 16.80 | 59.46 | 12.71 | 34.70 | 1,198,606 | 21.58 | 128.45% |
Halozyme Therapeutics Description
| Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally. |
